In a second criminal case against a pharmaceutical distributor and its executives this year, the Department of Justice has accused Ohio-based Miami-Luken and its former President and Compliance Officer of conspiring to...more
9/6/2019
/ Controlled Substances ,
Criminal Prosecution ,
DEA ,
Department of Justice (DOJ) ,
Distributors ,
Drug & Alcohol Abuse ,
Government Investigations ,
Internal Controls ,
Opioid ,
Pharmacies ,
Physicians ,
Prescription Drugs ,
Unjust Enrichment
Recent actions by the United States Department of Justice (DOJ) clearly demonstrate its focus on ensuring the effectiveness of both a corporation’s compliance program and its compliance officer....more